Darilia (drospirenone, ethinyl estradiol) coated tablets 3 mg/0.02 mg. №84

$63.00

Manufacturer: Hungary

Purpose: Inhibits ovulation, treats acne, and reduces the symptoms of premenstrual dysphoric disorder.

SKU: MED57593 Category:

Description

Darilia (Drospirenone, Ethinyl Estradiol) Coated Tablets 3 mg/0.02 mg. №84

Ingredients

Each coated tablet contains:

  • Drospirenone 3 mg
  • Ethinyl Estradiol 0.02 mg

Mechanism of Action

Darilia tablets contain a combination of drospirenone and ethinyl estradiol. Drospirenone is a progestin with antiandrogenic properties, and ethinyl estradiol is a synthetic estrogen. Together, they work by inhibiting ovulation, altering cervical mucus to prevent sperm penetration, and changing the endometrium to reduce the likelihood of implantation.

Pharmacological Properties

The pharmacological properties of Darilia tablets are attributed to the contraceptive effects of drospirenone and ethinyl estradiol. Drospirenone acts as a progestational compound with antimineralocorticoid and antiandrogenic activity, while ethinyl estradiol provides estrogenic effects.

Indications for Use

Darilia tablets are indicated for:

  • Prevention of pregnancy
  • Treatment of moderate acne vulgaris in females
  • Regulation of menstrual cycles

Contraindications

Do not use Darilia tablets if:

  • You are pregnant or breastfeeding
  • You have a history of thromboembolic disorders
  • You have liver disease

Side Effects

Common side effects of Darilia tablets may include nausea, breast tenderness, breakthrough bleeding, and headache. Serious side effects like blood clots and liver problems are rare but possible.

Usage Instructions

The recommended dosage is one tablet daily for 21 consecutive days, followed by a 7-day break.

Benefits Compared to Analogues

Darilia tablets offer a well-tolerated contraceptive method with additional benefits for skin health due to the antiandrogenic properties of drospirenone. Compared to other oral contraceptives, Darilia has a lower risk of causing water retention and weight gain.

Suitable Patient Groups

Darilia tablets are suitable for use in adult women, including adolescents who require contraception and treatment for acne. It is not recommended for use in pregnant women, breastfeeding mothers, or individuals with specific medical conditions.

Storage and Shelf Life

Store Darilia tablets at room temperature away from moisture and heat. Keep this medication out of reach of children. Check the expiration date on the packaging and do not use if expired.

Packaging Description

Darilia tablets are packaged in a box containing 84 coated tablets. Each tablet is individually sealed to maintain its integrity and potency.

Clinical Evidence and Proven Effectiveness

Studies have shown that the combination of drospirenone and ethinyl estradiol in Darilia tablets effectively prevents pregnancy and regulates menstrual cycles. Research published in the Journal of Contraception has demonstrated the high contraceptive efficacy of this formulation with a low incidence of side effects.

Additional Information

It is important to follow the prescribed dosage and schedule to ensure the effectiveness of Darilia tablets. Consult your healthcare provider for personalized advice and guidance.